Investment Objective
To Generate Long Term Capital Appreciation By Investing Predominantly In Equity And Equity Related Securities Of The Companies In Pharmaceuticals, Healthcare And Allied Sectors. There Is No Assurance That The…
Hold this fund?
See it next to everything else you own: every holding in one place, how it is allocated and how it is really doing.
At a glance
If you had invested
Loading NAV history.
Portfolio
As of 8 Oct 2026
Asset class
No data
Market cap
No data
Key figures
How it compares
Trailing Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | |
|---|---|---|---|---|---|---|---|---|---|
| This fund | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Calendar Year Returns vs Benchmark
Comparison with BSE Healthcare Index
More detail
Monthly returns, rolling returns, risk measures and the full NAV history.
Invesco India Pharma and Healthcare Fund Regular Plan Growth is a Sector Specific - Pharma equity fund from Invesco Asset Management Company Pvt Ltd., launched on 18 Aug 2026. Its benchmark is the BSE Healthcare Index. The expense ratio is 0.00% a year. It manages ₹0 crore. The NAV was ₹9.22 on 8 Oct 2026.
From 2026 to 2026, the fund returned more than the BSE Healthcare Index in 0 of 1 calendar years. The 2026 figure is year to date.
| Year | 2026 YTD |
|---|---|
| This fund | -4.60% |
| Benchmark | +19.04% |
Compare every pharma and healthcare fund on returns, volatility, worst fall and cost.
Wealth Home
Connect your mutual funds to see every holding in one place, how it is allocated, and how it is really doing.
Scan to connect on the app
iOS and Android. See your whole portfolio in a minute.